Given the large difference in APOE4 allele frequency in the AD and Control populations, differences in VGF (SME1) and NPTXR (SME2) may prove to be as related to presence or absence of APOE4 as to the diagnosis of AD. The gene discussed is APOE; the disease is Alzheimer disease.